- Home
- ABEO vs TWN Comparison
ABEO vs TWN Comparison
Compare ABEO & TWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- TWN
- Stock Information
- Founded
- ABEO 1974
- TWN 1986
- Country
- ABEO United States
- TWN Hong Kong
- Employees
- ABEO N/A
- TWN N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- TWN Trusts Except Educational Religious and Charitable
- Sector
- ABEO Health Care
- TWN Finance
- Exchange
- ABEO Nasdaq
- TWN Nasdaq
- Market Cap
- ABEO 256.9M
- TWN 285.6M
- IPO Year
- ABEO 1980
- TWN N/A
- Fundamental
- Price
- ABEO $6.59
- TWN $45.35
- Analyst Decision
- ABEO Strong Buy
- TWN
- Analyst Count
- ABEO 6
- TWN 0
- Target Price
- ABEO $18.00
- TWN N/A
- AVG Volume (30 Days)
- ABEO 1.2M
- TWN 20.1K
- Earning Date
- ABEO 08-11-2025
- TWN 01-01-0001
- Dividend Yield
- ABEO N/A
- TWN 1.10%
- EPS Growth
- ABEO N/A
- TWN N/A
- EPS
- ABEO N/A
- TWN N/A
- Revenue
- ABEO N/A
- TWN N/A
- Revenue This Year
- ABEO N/A
- TWN N/A
- Revenue Next Year
- ABEO $322.37
- TWN N/A
- P/E Ratio
- ABEO N/A
- TWN N/A
- Revenue Growth
- ABEO N/A
- TWN N/A
- 52 Week Low
- ABEO $3.93
- TWN $25.22
- 52 Week High
- ABEO $7.32
- TWN $41.51
- Technical
- Relative Strength Index (RSI)
- ABEO 66.16
- TWN 67.17
- Support Level
- ABEO $5.66
- TWN $44.36
- Resistance Level
- ABEO $5.99
- TWN $45.79
- Average True Range (ATR)
- ABEO 0.26
- TWN 0.49
- MACD
- ABEO 0.09
- TWN -0.25
- Stochastic Oscillator
- ABEO 76.92
- TWN 66.84
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.